TABLE 1.
Study design
Regimen and cohorta | Dosing schedule |
---|---|
Single-dose escalation | |
A | 50 mg for period 1; 800 mg for period 2 |
B | 200 mg for period 1; 1,200 mg for period 2 |
C | 400 mg for period 1; 400 mg + food for period 2 |
Repeat-dose escalation | |
D | 200 mg on day 1; 200 mg BID on days 2 to 8 |
E | 400 mg on day 1; 400 mg BID on days 2 to 8 |
F | 600 mg on day 1; 600 mg BID on days 2 to 8 |
G | 800 mg on day 1; 800 mg BID on days 2 to 8 |
For each cohort, n = 10 (8 active and 2 placebo).